KR950008317B1 - The preparation process of benzoxazine derivatives - Google Patents
The preparation process of benzoxazine derivatives Download PDFInfo
- Publication number
- KR950008317B1 KR950008317B1 KR1019920011834A KR920011834A KR950008317B1 KR 950008317 B1 KR950008317 B1 KR 950008317B1 KR 1019920011834 A KR1019920011834 A KR 1019920011834A KR 920011834 A KR920011834 A KR 920011834A KR 950008317 B1 KR950008317 B1 KR 950008317B1
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- compound
- benzoxazine
- dihydro
- oxo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/06—Peri-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Description
본 발명은 항균제로 사용되는 다음의 일반식(Ⅰ)을 갖는 9-할로-7-옥소-2,3--디히드로-7H-피리도[1,2,3-de][1,4] 벤즈옥사진-6-카르복실산 유도체와 제약상으로 허용되는 그 염의 제조에 관한 것이다.The present invention provides 9-halo-7-oxo-2,3--dihydro-7H-pyrido [1,2,3-de] [1,4] having the following general formula (I) to be used as an antibacterial agent. Benzoxazin-6-carboxylic acid derivatives and pharmaceutically acceptable salts thereof.
[화학식 1][Formula 1]
상기식에서 X는 할로겐 원자를 나타내고, R은 수소원자 또는 탄소 원자수 1에서 6의 알킬기를 표시하고, A는 단일 치환된 아미노기 또는 이 치환된 아미노기 또는 다른 헤테로원자를 함유하는 환상 치환 아미노기를 나타낸다. 단일 치환된 아미노기의 예로서, 모노메틸 아미노기, 모노에틸 아미노기를 포함하며 이 치환된 아미노기는 디메틸 아미노기, 디에틸 아미노기를 포함한다. 환상 치환 아미노기는 4에서 7원환을 가지는 아미노기를 말하며 그 예로서 아제티디닐, 피롤리디닐, 모르폴리닐, 피페라지닐 및 호모 피페라지닐이 포함되며, 보다 상세하게는 4-메틸-1-피페라지닐, 1-피페라지닐, 1-필로리디닐, 3-히드록시-1-피롤리디닐, 1-피페리디닐, 4-히드록시-1-피페리디닐, 3-히드록시-1-피페리디닐, 4-모르폴리닐, 4-(2-히드록시에틸)피페라지닐, 3,5-디메틸-1-피페라지닐, 4-디메틸아미노-1-피페리디닐, 호모 피페라지닐, 1-피라졸리딜, 2-메틸-1-피라졸리딜 등을 의미한다.Wherein X represents a halogen atom, R represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms, and A represents a cyclic substituted amino group containing a single substituted amino group or a substituted amino group or another heteroatom. As an example of a single substituted amino group, it includes a monomethyl amino group, a monoethyl amino group, and this substituted amino group includes a dimethyl amino group, a diethyl amino group. A cyclic substituted amino group refers to an amino group having a 4 to 7 membered ring, and examples thereof include azetidinyl, pyrrolidinyl, morpholinyl, piperazinyl and homo piperazinyl, and more specifically 4-methyl-1- Piperazinyl, 1-piperazinyl, 1-phyllolidinyl, 3-hydroxy-1-pyrrolidinyl, 1-piperidinyl, 4-hydroxy-1-piperidinyl, 3-hydroxy-1 -Piperidinyl, 4-morpholinyl, 4- (2-hydroxyethyl) piperazinyl, 3,5-dimethyl-1-piperazinyl, 4-dimethylamino-1-piperidinyl, homo pipera Genyl, 1-pyrazolidyl, 2-methyl-1-pyrazolidyl and the like.
본 발명의 화합물에 대한 제조방법으로서 대한민국 특허공보(B1) 공고번호 84-2141의 내용을 반응경로로 나타내면 아래와 같다.As a method for producing a compound of the present invention, the contents of the Republic of Korea Patent Publication (B1) Publication No. 84-2141 are represented by the reaction route as follows.
[반응식 1]Scheme 1
이러한 종래의 반응은 벤즈옥사진 링구조의 형성을 위하여 까다로운 조건에서 반응이 이루어지는 수소 첨가반응을 거치는 고리화 반응과, 퀴놀린 링구조의 형성을 이루는 고리화 반응의 두단계의 고리화반응을 거치고, 까다로운 분리과정을 거쳐야 한다. 이에 비하여 본 발명은 반응 공정수는 같으나 까다로운 수소 첨가반응을 피할 수 있는 새로운 제조방법을 제공한다.This conventional reaction is subjected to a two-step cyclization reaction of a cyclization reaction through a hydrogenation reaction in which the reaction is performed under difficult conditions to form a benzoxazine ring structure, and a cyclization reaction forming a quinoline ring structure, Difficult separation process In contrast, the present invention provides a new production method that can avoid the same hydrogenation reaction but the same number of reaction processes.
본 발명은 용이한 반응조건에서 높은 순도로 화합물(Ⅰ)을 제조하는 방법에 관한 것으로서, 종래의 방법과는 전혀 다른 반응경로를 갖는 것이 특징이며 본 발명의 반응경로를 기술하면 다음과 같다.The present invention relates to a method for preparing compound (I) with high purity under easy reaction conditions, which is characterized by having a completely different reaction route from the conventional method, and the following describes the reaction route of the present invention.
[반응식 2]Scheme 2
상기식에서 X, R 및 A는 앞에서 정의한 바와 같다.Wherein X, R and A are as defined above.
본 발명을 상세히 설명하면, 다음과 같다. 일반식(Ⅱ)의 방향족 아민 화합물과 일반식(Ⅲ)의 2-할로 에스테르 화합물을 산 수용체 존재하에서 반응시켜 일반식(Ⅳ)의 화합물을 얻는다. 이때 용매로서는 디메틸술폭시드, 디메틸포름아미드, 아세토니트릴 등의 극성이 큰 유기용매가 적당하며 반응조건으로서 산 수용체는 일반식(Ⅱ)의 화합물에 대하여 몰비로 1.0-5.0당량의 탄산나트륨 또는 탄산칼륨을 사용하고, 반응온도는 90-150℃, 반응시간은 8-24시간, 초매로는 크라운 에테르(Crown ether)를 사용하여 반응을 시키는 것이 바람직하다, 반응 후 추출, 건조, 여과, 증발 및 이들의 조합된 기술로서 일반식(Ⅳ)의 화합물을 얻고 이 화합물을 리튬알루미늄하이드라이드(LiAlH4) 또는 소디움보로하이드라이드(NaBH4)와 같은 환원제를 일반식(Ⅳ)의 화합물에 대하여 1.0-1.5당량 사용하여 환원시키면 일반식(Ⅴ)에 해당하는 화합물을 추출, 건조, 여과, 증발 분리 및 이들의 조합된 기술로서 얻는다. 이때의 반응조건은 용매로서 메탄올, 에탄올, 에테르 등의 유기 용매를 사용하고 상온에서 3-6시간 교반함으로써 반응을 완결시킨다.The present invention will be described in detail as follows. The aromatic amine compound of formula (II) and the 2-halo ester compound of formula (III) are reacted in the presence of an acid acceptor to obtain a compound of formula (IV). At this time, an organic solvent having high polarity such as dimethyl sulfoxide, dimethylformamide, acetonitrile and the like is suitable.As the reaction condition, the acid acceptor may use 1.0-5.0 equivalents of sodium carbonate or potassium carbonate in molar ratio to the compound of formula (II). The reaction temperature is 90-150 ° C., the reaction time is 8-24 hours, and it is preferable to perform the reaction using crown ether as a solvent. After the reaction, extraction, drying, filtration, evaporation, and As a combined technique, a compound of general formula (IV) is obtained and the reducing agent such as lithium aluminum hydride (LiAlH 4 ) or sodium borohydride (NaBH 4 ) is added to the compound of general formula (IV) 1.0-1.5. Reduction using an equivalent yields the compound of formula (V) as extraction, drying, filtration, evaporation separation and combination techniques thereof. At this time, the reaction conditions are completed by using organic solvents such as methanol, ethanol and ether as a solvent and stirring at room temperature for 3-6 hours.
얻어진 일반식(Ⅴ)의 화합물을 소듐하이드라이드(NaH), 포타슘하이드라이드(KH), 포타슘플로라이드(KF), 소듐알콕사이드(RONa), 포타슘알콕사이드(ROK)(여기에서 R은 탄소수 1-3의 알킬기이다)와 같은 강염기 존재하에서 반응을 시켜 일반식(Ⅵ)의 화합물을 얻는데 이때 반응조건으로서는 용매로서 디옥산, 디메틸포름아미드 등을 사용하고 반응온도는 70-150℃, 반응시간은 1-3시간이 바람직하다.The obtained compound of formula (V) is selected from sodium hydride (NaH), potassium hydride (KH), potassium fluoride (KF), sodium alkoxide (RONa) and potassium alkoxide (ROK), wherein R is carbon number 1-3 To a compound of formula (VI) by reaction in the presence of a strong base such as dioxane, dimethylformamide, etc. as reaction conditions. The reaction temperature is 70-150 ° C. and the reaction time is 1-. 3 hours is preferred.
얻어진 일반식(Ⅵ)의 화합물과 디에틸에톡시메틸렌 말로네이트 혹은 디메틸메톡시메틸렌 말로네이트와 반응을 시켜 일반식(Ⅵ)의 화합물을 얻는다. 이때 반응조건으로서는 용매존재하에서 혹은 용매없이 직접 일반식(Ⅵ)의 화합물과 디에틸에톡시메틸렌 말로네이트 혹은 디메틸메톡시메틸렌 말로네이트를 100-200℃의 온도에서 2-6시간 정도 반응시킨 후 상온에서 냉각하여 반응도중에 생긴 에탄올을 감압하에서 증류하여 제거하고 여기에 디페닐에테르와 같은 높은 비등점을 가지는 용매를 사용하여 150-250℃의 온도에서 2-4시간 정도 고리화반응을 시킨 후 상온으로 냉각하여 일반식(Ⅶ)의 화합물을 얻는다.The compound of the general formula (VI) is reacted with diethylethoxymethylene malonate or dimethylmethoxymethylene malonate to obtain a compound of the general formula (VI). At this time, as the reaction conditions, the compound of general formula (VI) and diethylethoxymethylene malonate or dimethylmethoxymethylene malonate were reacted at a temperature of 100-200 ° C. for 2-6 hours in a solvent or without solvent. The ethanol generated during the reaction was distilled off under reduced pressure, and then cyclized at 150-250 ° C. for 2-4 hours using a solvent having a high boiling point such as diphenyl ether. To obtain the compound of formula (VII).
또한, 고리화반응시 디페닐에테르 용매에서 폴리포스포릭산 혹은 그 에스테르를 촉매로 사용할 수 있으며, 또는 디페닐에테르 용매없이 폴리포스포릭산 혹은 그 에스테를 촉매 겸 용매로 사용하여 반응을 시킬 수 있다.In addition, polyphosphoric acid or its ester may be used as a catalyst in a diphenyl ether solvent during the cyclization reaction, or the reaction may be carried out using polyphosphoric acid or its ester as a catalyst and solvent without a diphenyl ether solvent. .
일반식(Ⅶ)의 화합물을 가수분해하여 일반식(Ⅷ)의 화합물을 얻는데, 가수분해 조건은 산 또는 염기 조건하에서 모두 가능하며 물, 디옥산, 메탄올, 에탄올 및 이들의 혼합용매에서 수산화나트륨, 수산화칼륨 등과 같은 염기로서 60-120℃ 정도에서 1-4시간 정도 반응을 시킨 후 반응혼합물을 냉각하여 초산 또는 염산으로 처리하여 고체를 생성시키거나 염산, 초산 또는 이들의 혼합액에서 일반식(Ⅶ)의 화합물을 60-120℃의 온도에서 1-4시간 정도 반응을 시킨 후 상온에서 냉각하여 생성된 고체를 여과, 증발, 재결정 및 이들의 조합된 기술의 방법으로 순수한 일반식(Ⅷ)의 화합물을 얻는다.The compound of formula (V) is hydrolyzed to obtain a compound of formula (V), which can be hydrolyzed under acidic or basic conditions, and sodium hydroxide in water, dioxane, methanol, ethanol and a mixed solvent thereof. After reacting with a base such as potassium hydroxide for about 1-4 hours at about 60-120 ° C, the reaction mixture is cooled and treated with acetic acid or hydrochloric acid to generate a solid, or in general form (HCl) in hydrochloric acid, acetic acid or a mixture thereof. After reacting the compound of about 1-4 hours at a temperature of 60-120 ℃ and cooling at room temperature, the solid produced by filtration, evaporation, recrystallization and a combination of these techniques to obtain a pure compound of general formula (Ⅷ) Get
얻어진 일반식(Ⅷ)의 화합물을 일반식 AH의 아민 화합물과 반응시켜 목적물질인 일반식(Ⅰ)의 화합물을 얻는데, 이때 반응조건으로서는 몰비로 1.2-5.0당량에 해당하는 일반식 AH의 아민과 일반식(Ⅷ)의 화합물을 디메틸포름아미드, 디메틸술폭시드와 같은 극성용매를 사용하여 100-150℃의 온도에서 10-20시간 반응시킨 후 상온으로 냉각하여 여과, 추출, 증발, 재결정 및 이들의 조합된 기술의 방법으로 순수한 일반식(Ⅰ)의 화합물을 얻을 수 있으며, 얻어진 일반식(Ⅰ)의 화합물은 독성이 적으며 그램 음성균 또는 그램 양성균에 탁월한 항균활성을 지닌다.The obtained compound of formula (VIII) is reacted with an amine compound of formula AH to obtain a compound of formula (I) as a target substance, wherein reaction conditions include an amine of formula AH corresponding to 1.2-5.0 equivalents in molar ratio. After reacting the compound of the formula (10) with a polar solvent such as dimethylformamide and dimethyl sulfoxide at a temperature of 100-150 ° C for 10-20 hours, cooling it to room temperature, it is filtered, extracted, evaporated, recrystallized and their The compound of general formula (I) can be obtained by the combined technique, and the obtained compound of general formula (I) is less toxic and has excellent antimicrobial activity against gram negative bacteria or gram positive bacteria.
다음의 실시예로서 본 발명을 상세히 설명한다.The present invention is explained in detail by the following examples.
[실시예 1]Example 1
1) 에틸 2-(3,3,4-트리플루오로페닐)아미노프로판산 에스테르의 제조.1) Preparation of ethyl 2- (3,3,4-trifluorophenyl) aminopropanoic acid ester.
2,3,4-트리플루오로아닐린 5.0g, 탄산칼륨 4.7g, 2-브로모프로탄산 에틸에스테르 6.8g, 18-크라운-6-에테르 0.5g을 디메틸포름아미드 용매에 혼합하여 100℃에서 12시간 동안 가열 후 냉각하여 반응혼합액을 물과 에틸아세테이트를 첨가하여 섞어준 다음 유기층을 분리한 후 건조시켜 용매를 감압하에서 제거하였다. 용매를 제거한 후 생긴 잔사를 실리카겔 크로마토그래피로 정제하여 에틸 2-(2,3,4-트리플루오로페닐)아미노프로판산 에스테르 5.0g을 얻었다.5.0 g of 2,3,4-trifluoroaniline, 4.7 g of potassium carbonate, 6.8 g of 2-bromopropanoic acid ethyl ester, and 0.5 g of 18-crown-6-ether were mixed with a dimethylformamide solvent to obtain 12 After heating for a while, the mixture was cooled and the reaction mixture was mixed with water and ethyl acetate. The organic layer was separated and dried to remove the solvent under reduced pressure. After removing the solvent, the resulting residue was purified by silica gel chromatography to obtain 5.0 g of ethyl 2- (2,3,4-trifluorophenyl) aminopropanoic acid ester.
2) N-(1-히드록시프로-2-필)-2,3,4-트리플루오로아닐린의 제조.2) Preparation of N- (1-hydroxypro-2-fil) -2,3,4-trifluoroaniline.
에틸 2-(3,3,4-트리플루오로페닐)아미노프로판산 에스테르 5.0g을 에테르 100㎖에 녹인 후 리튬알루미늄하이드라이드 0.8g을 넣어 상온에서 1시간동안 반응시키고 다시 3시간 도안 환류시켰다. 반응 후 묽은 염산으로 중화시키고 에틸 에테르로 추출하고 건조, 농축하여 N-(1-히드록시프로-2-필)-2,3,4-트리플루오로아닐린 3.3g을 얻었다.5.0 g of ethyl 2- (3,3,4-trifluorophenyl) aminopropanoic acid ester was dissolved in 100 ml of ether, 0.8 g of lithium aluminum hydride was added thereto, and reacted at room temperature for 1 hour, followed by reflux for 3 hours. After the reaction was neutralized with diluted hydrochloric acid, extracted with ethyl ether, dried and concentrated to obtain 3.3 g of N- (1-hydroxyprop-2- pil) -2,3,4-trifluoroaniline.
3) 7,8-디플루오로-2,3-디히드로-3-메틸-4H-1,4-벤즈옥사진의 제조.3) Preparation of 7,8-difluoro-2,3-dihydro-3-methyl-4H-1,4-benzoxazine.
N-(1-히드록시프로-2-필)-2,3,4-트리플루오로벤젠 3.0g, 포타슘플로라이드 0.9g을 디메틸포름아미드 50㎖에 혼합하여 3시간 동안 환류시킨 후 상온으로 냉각하여 용매를 감압하에서 제거하였다. 잔사에 크로로포름과 물을 넣어 섞어준 다음 유기층을 분리한 후 건조시켜 용매를 감압하에서 제거하고 잔사를 실리카겔 크로마토그래프로 정제하여 순수한 7,8-디플루오로-2,3-디히드로-3-메틸-4H-1,4-벤즈옥사진 2.2g을 얻었다.3.0 g of N- (1-hydroxypro-2-fil) -2,3,4-trifluorobenzene and 0.9 g of potassium fluoride were mixed in 50 ml of dimethylformamide, refluxed for 3 hours, and cooled to room temperature. The solvent was removed under reduced pressure. The residue was mixed with chloroform and water, and then the organic layer was separated and dried to remove the solvent under reduced pressure, and the residue was purified by silica gel chromatography to obtain pure 7,8-difluoro-2,3-dihydro-3. 2.2 g of -methyl-4H-1,4-benzoxazine was obtained.
4) 9,10-디플루오로-2,3-디히드로-3-메틸-7-옥소-7H-피리드[1,2,3,-de][1,4]벤즈옥사진-6-카르복실산의 제조.4) 9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrid [1,2,3, -de] [1,4] benzoxazine-6- Preparation of Carboxylic Acids.
7,8-디플루오로-2,3-디히드로-3-메틸-4h-1,4-벤즈옥사진 3.0g, 디에틸 에톡시메틸렌 말로네이트 5.3g을 용매없이 혼합하여 130℃에서 4시간 동안 가열한 후 부산물인 에탄올을 제거하고 여기에 폴리포스포릭산 에틸에스테르 20.0g을 넣어 다시 4시간 동안 가열하였다. 반응용기에 찬물을 넣고 크로로포름으로 추출한 후 클로로포름층을 탄산칼륨 수용액으로 씻어준 후 건조하고 감압농축하여 얻는 화합물에 초산-염산(2/1) 50㎖를 가하여 4시간 동안 환류시켰다. 반응용기를 상온으로 냉각하여 생성된 고체를 여과하여 9,10-7,8-디플루오로-2,3-디히드로-3-메틸-7-옥소-7H-피리드[1,2,3-de][1,4]벤즈옥사진-6-카르복실산 2.7g을 얻었다.3.0 g of 7,8-difluoro-2,3-dihydro-3-methyl-4h-1,4-benzoxazine and 5.3 g of diethyl ethoxymethylene malonate were mixed without a solvent for 4 hours at 130 ° C. After heating for 2 hours, by-product ethanol was removed, and 20.0 g of polyphosphoric acid ethyl ester was added thereto, followed by heating for 4 hours. Cold water was added to the reaction vessel, and the mixture was extracted with chloroform. The chloroform layer was washed with an aqueous potassium carbonate solution, dried and concentrated under reduced pressure, and 50 ml of acetic acid-hydrochloric acid (2/1) was added to reflux for 4 hours. The reaction vessel was cooled to room temperature, and the resulting solid was filtered to give 9,10-7,8-difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyride [1,2,3 -de] [1,4] benzoxazine-6-carboxylic acid 2.7 g was obtained.
5) 9-플루오로-2,3-디히드로-3-메틸-10-(4-메틸-1-피페라지닐)-7-옥소-7H-피리도-[1,2,3-de][1,4]벤즈옥사진-6-카르복실산의 제조.5) 9-fluoro-2,3-dihydro-3-methyl-10- (4-methyl-1-piperazinyl) -7-oxo-7H-pyrido- [1,2,3-de] Preparation of [1,4] benzoxazine-6-carboxylic acid.
9,10-디플루오로-2,3-디히드로-3-메틸-7-옥소-7H-피리도[1,2,3-de][1,4]벤즈옥사진-6-카르복실산 1.0g, N-메틸피페라진 0.5g, 피리딘 1.5g, 디메틸술폭시드 5㎖를 혼합하여 120-140℃의 온도에서 12시간 가열한 후 감압하에서 용매를 제거하였다. 반응용기에 물을 넣어 생성된 고체를 여과한 후 에탄올로 재결정하여 순수한 9-플루오로-2,3-디히드로-3-메틸-10-(4-메틸-1-피페라지닐)-7-옥소-7H-피리도-[1,2,3-de][1,4]벤즈옥사진-6-카르복실산 0.84g을 얻는다.9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido [1,2,3-de] [1,4] benzoxazine-6-carboxylic acid 1.0 g, 0.5 g of N-methylpiperazine, 1.5 g of pyridine, and 5 ml of dimethyl sulfoxide were mixed and heated at a temperature of 120-140 ° C. for 12 hours, and then the solvent was removed under reduced pressure. Water was added to the reaction vessel, and the resulting solid was filtered and recrystallized with ethanol to obtain pure 9-fluoro-2,3-dihydro-3-methyl-10- (4-methyl-1-piperazinyl) -7- 0.84 g of oxo-7H-pyrido- [1,2,3-de] [1,4] benzoxazine-6-carboxylic acid is obtained.
녹는점 : 250-257℃(분해)Melting Point: 250-257 ℃ (Decomposition)
[실시예 2]Example 2
실시예 1의 제1공정에서 2,3,4,-트리플루오로아닐린 대신에 2,3,4-트리클로로아닐린 5.0g을 투입한 것을 제외하고는 실시예 1과 동일조건과 방법으로 반응시켜 9-클로로-2,3-디히드로-3-메틸-10-(4-메틸-1-피페라지닐)-7-옥소-7H-피리도-[1,2,3-de][1,4]벤즈옥사진-6-카르복실산 0.82g을 얻었다.The reaction was carried out in the same manner as in Example 1, except that 5.0 g of 2,3,4-trichloroaniline was added instead of 2,3,4, -trifluoroaniline in the first step of Example 1. 9-chloro-2,3-dihydro-3-methyl-10- (4-methyl-1-piperazinyl) -7-oxo-7H-pyrido- [1,2,3-de] [1, 4] 0.82 g of benzoxazine-6-carboxylic acid was obtained.
[실시예 3]Example 3
실시예 2의 제5공정에서 N-메틸피페라진 대신에 피페라진 0.45g을 투입하는 것을 제외하고는 실시예 1과 동일 조건과 방법으로 반응시켜 9-플루오로-2,3-디히드로-3-메틸-10-피페라지닐-7-옥소-7H-피리도-[1,2,3-de][1,4]벤즈옥사진-6-카르복실산 0.79g을 얻었다.In the fifth step of Example 2, except that 0.45 g of piperazine was added instead of N-methylpiperazine, 9-fluoro-2,3-dihydro-3 was reacted in the same manner as in Example 1. 0.79 g of -methyl-10-piperazinyl-7-oxo-7H-pyrido- [1,2,3-de] [1,4] benzoxazine-6-carboxylic acid was obtained.
녹는점 : 257-260℃(분해)Melting Point: 257-260 ℃ (Decomposition)
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019920011834A KR950008317B1 (en) | 1992-07-03 | 1992-07-03 | The preparation process of benzoxazine derivatives |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019920011834A KR950008317B1 (en) | 1992-07-03 | 1992-07-03 | The preparation process of benzoxazine derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
KR940002250A KR940002250A (en) | 1994-02-17 |
KR950008317B1 true KR950008317B1 (en) | 1995-07-27 |
Family
ID=19335817
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019920011834A KR950008317B1 (en) | 1992-07-03 | 1992-07-03 | The preparation process of benzoxazine derivatives |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR950008317B1 (en) |
-
1992
- 1992-07-03 KR KR1019920011834A patent/KR950008317B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR940002250A (en) | 1994-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1167840A (en) | Benzoxazine derivatives | |
Matsumoto et al. | 1, 4-Dihydro-4-oxopyridinecarboxylic acids as antibacterial agents. 2. Synthesis and structure-activity relationships of 1, 6, 7-trisubstituted 1, 4-dihydro-4-oxo-1, 8-naphthyridine-3-carboxylic acids, including enoxacin, a new antibacterial agent | |
GB2086905A (en) | Benzoheterocyclic compounds and process for preparing same | |
KR880002353B1 (en) | Quinoline compounds and process for the preparation thereof | |
US3192204A (en) | Trifluoromethylthiaxanthene and -xanthene derivatives | |
CA2048511A1 (en) | Tricyclic compound or salts thereof, method for producing the same and antimicrobial agent containing the same | |
JPH0477B2 (en) | ||
US4213985A (en) | Novel 5,11-dihydro-6H-pyrido-[2,3-b][1,4]-benzodiazepine-6-ones | |
CA1153374A (en) | Piperazinylbenzoheterocyclic compounds | |
IE58312B1 (en) | Heterocyclic derivatives, processes for their preparation and drugs in which they are present, which are useful especially as aldose reductase inhibitors | |
JPH07501835A (en) | Process for producing benzoxazine used in the synthesis of ofloxazine, levofloxazine and derivatives | |
US2919271A (en) | 3-amino-1, 2-dihydro-3h-pyrido [3, 2, 1-kl]-phenothiazines | |
KR950008317B1 (en) | The preparation process of benzoxazine derivatives | |
EP0101829B1 (en) | Tricyclic compounds, a process for their production and pharmaceutical compositions containing said compounds | |
KR970005310B1 (en) | The process of preparing benzoxazine derivatives | |
JPH0116837B2 (en) | ||
KR940004811B1 (en) | Process for preparing benzoxazine derivatives | |
EP1189903A1 (en) | Novel benzo f]naphthyridine, preparation and compositions containing them | |
HUT56366A (en) | Process for producing diazobicycloamine derivatives | |
EP0203795B1 (en) | Benzo [i,j] quinolizine-2-carboxylic acid derivatives, the salts and their hydrates, pharmaceutical compositions thereof, and process for preparing the same | |
KR960015032B1 (en) | The process for preparing benzoxazine derivatives | |
KR940009792B1 (en) | Process for preparing benzoxazine carboxylic acid derivatives | |
EP0008610B1 (en) | Furonaphthyridine compounds, process for their preparation and pharmaceutical compositions containing them | |
JPH02247177A (en) | Benzo(b)(1,8)naphthyridine derivative and preparation thereof | |
KR100248370B1 (en) | Preparation of intermediate of (-)-3(s)-methylpyrido benzoxizine derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
LAPS | Lapse due to unpaid annual fee |